期刊文献+

人胰岛素瘤相关蛋白-2基因的克隆及原核表达研究 被引量:2

Molecular Cloning and Prokaryotic Expression of Human Insulinnoma Associated Protein - 2 Gene
下载PDF
导出
摘要 目的 克隆1型糖尿病自身抗原人胰岛素瘤相关蛋白-2(IA-2)的编码基因,并从大肠杆菌中表达具有免疫原性的人IA-2重组蛋白。 方法 抽提胎脑总RNA,通过RT-PCR获得编码IA-2胞内结构域的cDNA,与Pinpoint Xa-1T质粒相连接,构建表达型重组质粒,经转化、筛选并鉴定后,从大肠杆菌诱导表达生物素酰化融合蛋白,进而用亲和层析纯化之,以dot-blot鉴定其免疫原性。 结果 重组质粒转化的大肠杆菌经IPTG诱导表达及亲和层析后得到了纯度较高、分子量约为59kd的融合蛋白,表达产物用dot-blot证明具有免疫原性。 结论 原核表达的生物素酰化人IA-2胞内段融合蛋白具有正确的免疫学构象。 Objective To get cDNA that encodes human insulinnoma associated protein - 2 (IA -2) and to get E. coli derived IA -2 recombinant protein with immunological activity. Methods The cD-NA coding for the intracytoplasmic domain of IA -2 (IA -2ic) was amplified from human fetal brain RNA by RT - PCR, and was cloned into the PinPoint Xa -IT vector to construct recombinant expression plas-mid, and was then expressed in E. coli as a fusion protein with a biotinylated peptide sequence at the amin-oterminus. The biotinylated fusion protein was then purified by affinity chromatography and its immunogenicity was evaluated by dot - blot. Results The purified IA -2ic fusion protein resolved on SDS - PAGE as a single Coomassie brilliant blue - stained band with a molecular weight of 59kd and its immunogenicity was confirmed by dot - blot. Conclusion E. coli derived IA -2ic fusion protein has correct immunogen-ic conformation.
出处 《上海第二医科大学学报》 CSCD 2003年第3期196-199,共4页 Acta Universitatis Medicinalis Secondae Shanghai
基金 上海市卫生局科技发展基金(00418) 上海高校自然科学研究基金(2000B16)资助课题
关键词 胰岛素瘤相关蛋白-2 克隆 原核表达 1型糖尿病 自身抗原 大肠杆菌 RT-PCR type 1 diabetes IA - 2 autoantigen autoantibodies
  • 相关文献

参考文献9

  • 1Bonifacio E, Lampasona V, Bingley PJ. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigen [J]. J Immunol, 1998, 161:2648-2654.
  • 2Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus: measurements with a new immunoprecipitation assay [J]. Clinica Chimica Acta, 2000, 291:53-66.
  • 3Lobner K, Khoo-Morgenthaler UY, Seissler J, et al. Detection of autoantibodies to the diabetes-associated antigen IA-2 by a sensitive enzyme-linked immunosorbent assay [J]. Horm Metab Res, 1999, 31:686-691.
  • 4Balaji M, Shtauvere BA, Balaji V, et al. Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens [J]. Ann N Y Acad Sci, 2002, 958:281-284.
  • 5Grasso YZ, Reddy SK, Rosenfeld CR, et al. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features [J]. Endocr Pract, 2001, 7 (5):339-345.
  • 6Hawkes CJ, Schloot NC, Marks J, et al. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase like autoantigen IA-2 in type 1 diabetes [J]. Diabetes, 2000, 49 (3): 356-366.
  • 7Pastore MR, Balini A, Bazzigaluppi E, et al. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives [J]. Diabetes Care, 1998, 21: 1445-1450.
  • 8Kolm LV, Berlo S, Bonifacio E, et al. Human monoclonal antibodies isolated from type 1 diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen [J]. J Immunol, 2000, 165 (8):4676-4684.
  • 9Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibodies, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop [J]. Diabetes, 1998, 47: 1857-1866.

同被引文献5

  • 1Lan MS,Wasserfall C,Maclaren NK,et al.IA-2,a transmembrane protein of the protein tyrosine phosphatase family,is a major autoantigen in insulin-dependent diabetes mellitus[J].Proc Natl Acad Sci USA,1996,93 (13):6367-6370.
  • 2Zhang B,Lan MS,Notkins AL.Autoantibodies to IA-2 in IDDM:location of major antigenic determinants[J].Diabetes,1997,46(1):40 -43.
  • 3Vogt RF Jr,Phillips DL,Henderson LO,et al.Quantitative differences among various protein as blocking agents for ELISA microtiter plates[J].J Immunol Methods,1987,101 (1):43-50.
  • 4Seissler J,de Sonnaville JJJ,Morgenthaler NG,et al.Immunological heterogeneity in type 1 diabetes:presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease[J].Diabetologia,1998,41 (8):891-897.
  • 5Inukai T,Fujiwara Y,Tayama K,et al.Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase[J].Exp Clin Endocrinol Diabetes,1997,105(6):327 -330.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部